Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Salmon

Showing results (201-210 of 211) with videos related to

Pageof 22
Sort By:
Journal of Alzheimer'S Disease : JAD|August 2, 2021
Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer's Disease in a Clinical Setting: A REMEMBER StudyMandy Melissa Jane Wittens, Diana Maria Sima, Ruben Houbrechts, et al.
Acta Neuropathologica|March 16, 2019
Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitabilityRita Cacace, Bavo Heeman, Sara Van Mossevelde, et al.
Brain : a Journal of Neurology|February 20, 2015
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stageStephanie J B Vos, Frans Verhey, Lutz Frölich, et al.
Neurobiology of Aging|May 9, 2017
The frequency and influence of dementia risk factors in prodromal Alzheimer's diseaseIsabelle Bos, Stephanie J Vos, Lutz Frölich, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 7, 2017
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium studyPaolo Bosco, Alberto Redolfi, Martina Bocchetta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 25, 2014
The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC surveyMartina Bocchetta, Samantha Galluzzi, Patrick Gavin Kehoe, et al.
Neurobiology of Aging|June 11, 2018
No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patientsYalda Baradaran-Heravi, Lubina Dillen, Hung Phuoc Nguyen, et al.
The Journal of Prevention of Alzheimer'S Disease|July 10, 2025
Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s diseaseFrank Jessen, Javier Arbizu, Mercé Boada, et al.
Human Mutation|December 24, 2016
TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral SclerosisJulie van der Zee, Ilse Gijselinck, Sara Van Mossevelde, et al.
Acta Neuropathologica|June 6, 2014
Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degenerationJulie van der Zee, Tim Van Langenhove, Gabor G Kovacs, et al.
Pageof 22

Showing results (201-210 of 211) with videos related to

Sort By:
Pageof 22
Journal of Alzheimer'S Disease : JAD|August 2, 2021
Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer's Disease in a Clinical Setting: A REMEMBER StudyMandy Melissa Jane Wittens, Diana Maria Sima, Ruben Houbrechts, et al.
Acta Neuropathologica|March 16, 2019
Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitabilityRita Cacace, Bavo Heeman, Sara Van Mossevelde, et al.
Brain : a Journal of Neurology|February 20, 2015
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stageStephanie J B Vos, Frans Verhey, Lutz Frölich, et al.
Neurobiology of Aging|May 9, 2017
The frequency and influence of dementia risk factors in prodromal Alzheimer's diseaseIsabelle Bos, Stephanie J Vos, Lutz Frölich, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 7, 2017
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium studyPaolo Bosco, Alberto Redolfi, Martina Bocchetta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 25, 2014
The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC surveyMartina Bocchetta, Samantha Galluzzi, Patrick Gavin Kehoe, et al.
Neurobiology of Aging|June 11, 2018
No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patientsYalda Baradaran-Heravi, Lubina Dillen, Hung Phuoc Nguyen, et al.
The Journal of Prevention of Alzheimer'S Disease|July 10, 2025
Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s diseaseFrank Jessen, Javier Arbizu, Mercé Boada, et al.
Human Mutation|December 24, 2016
TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral SclerosisJulie van der Zee, Ilse Gijselinck, Sara Van Mossevelde, et al.
Acta Neuropathologica|June 6, 2014
Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degenerationJulie van der Zee, Tim Van Langenhove, Gabor G Kovacs, et al.
Pageof 22